Brought to you by 
Thiakis closes £10mm Series A round
29 Aug 2006
Executive Summary
Thiakis Ltd. (obesity treatments) brought in £10mm ($18.8mm) with its Series A financing led by first-time backers Novo AS and Advent Venture Partners. Returning shareholder Imperial Innovations (tech transfer arm of Imperial College London) was joined by new investors The Royal Society, Esperante, Consensus Business Group, and NPI Ventures.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Thiakis closes £10mm Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice